CTA
IDXX icon

Chesley Taft & Associates’s Idexx Laboratories IDXX Stock Holding History

Chesley Taft & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,248
Closed -$821K – 272
2017
Q4 		$821K Hold
5,248
– – 0.07% 190
2017
Q3 		$816K Hold
5,248
– – 0.07% 189
2017
Q2 		$847K Hold
5,248
– – 0.08% 185
2017
Q1 		$811K Sell
5,248
-352
-6% -$48.5K 0.08% 191
2016
Q4 		$657K Buy
+5,600
New +$639K 0.07% 198

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Chesley Taft & Associates's IDXX Position: Q1 2018 in Review

Chesley Taft & Associates sold out of Idexx Laboratories (IDXX) in Q1 2018, closing a stake of 5,248 shares — an estimated $821K sold.

Chesley Taft & Associates first reported a position in IDXX in Q4 2016 and held it in 5 quarters. The position peaked at $847K in Q2 2017. 646 funds tracked by Wall St. Rank hold IDXX as of Q1 2018.

  • Chesley Taft & Associates reported no remaining Idexx Laboratories position as of Q1 2018 after selling out during the quarter.
  • Chesley Taft & Associates sold 5,248 Idexx Laboratories shares in Q1 2018, an estimated $821K.
  • Chesley Taft & Associates first reported a position in Idexx Laboratories in Q4 2016 and held it in 5 quarters.
  • Chesley Taft & Associates's Idexx Laboratories position peaked at $847K in Q2 2017.
  • 646 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2018.

Based on Chesley Taft & Associates's 13F filing for Q1 2018, filed 11 Apr 2018.